Page last updated: 2024-10-22

amantadine and Ataxia Telangiectasia Syndrome

amantadine has been researched along with Ataxia Telangiectasia Syndrome in 1 studies

amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source

Research Excerpts

ExcerptRelevanceReference
"Amantadine is a well-tolerated and effective treatment for motor symptoms in ataxia telangiectasia."2.78Movement disorder in ataxia-telangiectasia: treatment with amantadine sulfate. ( Ben-Zeev, B; Hassin-Baer, S; Lerman, SF; Levi, YB; Nissenkorn, A; Tzadok, M, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nissenkorn, A1
Hassin-Baer, S1
Lerman, SF1
Levi, YB1
Tzadok, M1
Ben-Zeev, B1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effect of Amantadine on Movement Disorder in Ataxia-Telangiectasia[NCT00950196]Phase 430 participants (Anticipated)Interventional2008-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for amantadine and Ataxia Telangiectasia Syndrome

ArticleYear
Movement disorder in ataxia-telangiectasia: treatment with amantadine sulfate.
    Journal of child neurology, 2013, Volume: 28, Issue:2

    Topics: Adolescent; Amantadine; Antiparkinson Agents; Ataxia Telangiectasia; Child; Child, Preschool; Disabi

2013